Brief: GlycoMimetics Announces Initiation Of Clinical Trial Evaluating Uproleselan In Combination With Venetoclax And Azacitidine
12/07/2021 14:02
July 12 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS ANNOUNCES INITIATION OF CLINICAL TRIAL
EVALUATING
UPROLESELAN IN COMBINATION WITH VENETOCLAX AND AZACITIDINE
Source text for Eikon: ID:nBw67KcNQa
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering